Erratum

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, Michael W Steffes

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Number of pages1
JournalDiabetes
Volume53
Issue number7
DOIs
StatePublished - Jul 1 2004

Fingerprint

C-Peptide
Type 1 Diabetes Mellitus
Outcome Assessment (Health Care)
Clinical Trials
Education

Cite this

Erratum : C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)). / Palmer, J. P.; Fleming, G. A.; Greenbaum, C. J.; Herold, K. C.; Jansa, L. D.; Kolb, H.; Lachin, J. M.; Polonsky, K. S.; Pozzilli, P.; Skyler, J. S.; Steffes, Michael W.

In: Diabetes, Vol. 53, No. 7, 01.07.2004.

Research output: Contribution to journalComment/debate

Palmer, J. P. ; Fleming, G. A. ; Greenbaum, C. J. ; Herold, K. C. ; Jansa, L. D. ; Kolb, H. ; Lachin, J. M. ; Polonsky, K. S. ; Pozzilli, P. ; Skyler, J. S. ; Steffes, Michael W. / Erratum : C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)). In: Diabetes. 2004 ; Vol. 53, No. 7.
@article{2214930a9db54eafba82a362f95543fd,
title = "Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))",
author = "Palmer, {J. P.} and Fleming, {G. A.} and Greenbaum, {C. J.} and Herold, {K. C.} and Jansa, {L. D.} and H. Kolb and Lachin, {J. M.} and Polonsky, {K. S.} and P. Pozzilli and Skyler, {J. S.} and Steffes, {Michael W}",
year = "2004",
month = "7",
day = "1",
doi = "10.2337/diabetes.53.7.1934",
language = "English (US)",
volume = "53",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "7",

}

TY - JOUR

T1 - Erratum

T2 - C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

AU - Palmer, J. P.

AU - Fleming, G. A.

AU - Greenbaum, C. J.

AU - Herold, K. C.

AU - Jansa, L. D.

AU - Kolb, H.

AU - Lachin, J. M.

AU - Polonsky, K. S.

AU - Pozzilli, P.

AU - Skyler, J. S.

AU - Steffes, Michael W

PY - 2004/7/1

Y1 - 2004/7/1

UR - http://www.scopus.com/inward/record.url?scp=3042822067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042822067&partnerID=8YFLogxK

U2 - 10.2337/diabetes.53.7.1934

DO - 10.2337/diabetes.53.7.1934

M3 - Comment/debate

VL - 53

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 7

ER -